scholarly article | Q13442814 |
P356 | DOI | 10.1172/JCI23559 |
P8608 | Fatcat ID | release_4qaahobwrfg33idsh7s6kkape4 |
P3181 | OpenCitations bibliographic resource ID | 1627289 |
P932 | PMC publication ID | 1172228 |
P698 | PubMed publication ID | 16007267 |
P50 | author | Armin Schneider | Q30764723 |
Hans-Georg Kuhn | Q56441816 | ||
Walter Mier | Q88713133 | ||
Martin Hasselblatt | Q39062301 | ||
Martin Maurer | Q43105102 | ||
P2093 | author name string | Stefan Schwab | |
Nikolaus Gassler | |||
Rico Laage | |||
Wolf-Rüdiger Schäbitz | |||
Rainer Kollmar | |||
Jaroslaw Aronowski | |||
Alfred Bach | |||
Daniela Weber | |||
Clemens Sommer | |||
Carola Krüger | |||
Tobias Steigleder | |||
Claudia Pitzer | |||
P2860 | cites work | Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons | Q28139253 |
Induction of neurogenesis in the neocortex of adult mice | Q28139868 | ||
Theta band oscillation and synchrony in the hippocampal formation and associated structures: the case for its role in sensorimotor integration | Q28206701 | ||
Transient expression of doublecortin during adult neurogenesis | Q28212071 | ||
Induction of reproducible brain infarction by photochemically initiated thrombosis | Q28235221 | ||
NeuN, a neuronal specific nuclear protein in vertebrates | Q28510657 | ||
Cloning and characterization of the 5'-flanking region of the rat neuron-specific Class III beta-tubulin gene | Q28580697 | ||
Programmed cell death of adult-generated hippocampal neurons is mediated by the proapoptotic gene Bax | Q28585790 | ||
Regulation of neuronal survival by the serine-threonine protein kinase Akt | Q29614185 | ||
Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus | Q29615348 | ||
Neuronal replacement from endogenous precursors in the adult brain after stroke | Q29615772 | ||
Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. | Q31134470 | ||
Enhanced neurogenesis after transient global ischemia in the dentate gyrus of the rat. | Q32174329 | ||
Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival | Q33940371 | ||
Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus | Q33954181 | ||
Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha | Q48427106 | ||
Impaired adult neurogenesis in mice lacking the transcription factor E2F1. | Q48459656 | ||
Granulocyte-macrophage colony-stimulating factor crosses the blood--brain and blood--spinal cord barriers | Q48586998 | ||
Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. | Q48692503 | ||
Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction | Q68459611 | ||
Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors | Q68799816 | ||
Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells | Q71611719 | ||
Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells | Q72090049 | ||
Behavioral deficits following experimental subarachnoid hemorrhage in the rat | Q72897496 | ||
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury | Q73503153 | ||
Effects of colony-stimulating factors (CSFs) on neutrophil apoptosis: possible roles at inflammation site | Q73643355 | ||
Cortical neurogenesis in adult rats after reversible photothrombotic stroke | Q74195845 | ||
Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain | Q74233473 | ||
Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells | Q80593656 | ||
Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor | Q80783829 | ||
Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor | Q34049948 | ||
Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb | Q34067026 | ||
Bcl-2 family gene products in cerebral ischemia and traumatic brain injury | Q34076414 | ||
An overview of acute stroke therapy: past, present, and future | Q34087892 | ||
Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. | Q34090264 | ||
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor | Q34192924 | ||
Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway | Q34278037 | ||
Analysis of serial measurements in medical research | Q35167613 | ||
Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat | Q35298897 | ||
Proliferation, differentiation, and long-term culture of primary hippocampal neurons | Q36253429 | ||
Coexpression of neurotrophins and their receptors in neurons of the central nervous system | Q36427306 | ||
Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats | Q36888097 | ||
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury | Q37250532 | ||
Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia | Q40397077 | ||
Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. | Q40898197 | ||
Use-dependent structural events in recovery of function | Q41261889 | ||
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis | Q41748320 | ||
Functional connectivity between the red nucleus and the hippocampus supports the role of hippocampal formation in sensorimotor integration | Q42462532 | ||
A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. | Q42536958 | ||
Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia | Q42691824 | ||
Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum | Q42835101 | ||
Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines | Q42994196 | ||
Cortical neurogenesis in adult rats after transient middle cerebral artery occlusion | Q43599424 | ||
Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells | Q43694502 | ||
N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke | Q43698114 | ||
Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system | Q43845852 | ||
Long-term survival and cell death of newly generated neurons in the adult rat olfactory bulb | Q44216003 | ||
Theta- and movement velocity-related firing of hippocampal neurons is disrupted by lesions centered on the perirhinal cortex | Q44354678 | ||
Short-term and long-term survival of new neurons in the rat dentate gyrus | Q44419578 | ||
Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis | Q44465567 | ||
Exercise increases hippocampal neurogenesis to high levels but does not improve spatial learning in mice bred for increased voluntary wheel running | Q44626424 | ||
VEGF is necessary for exercise-induced adult hippocampal neurogenesis | Q44680412 | ||
Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. | Q46341741 | ||
Migration patterns of subventricular zone cells in adult mice change after cerebral cortex injury | Q47294785 | ||
Restriction-mediated differential display (RMDD) identifies pip92 as a pro-apoptotic gene product induced during focal cerebral ischemia | Q48026245 | ||
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia | Q48027101 | ||
Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. | Q48267353 | ||
Behavioral transitions modulate hippocampal electroencephalogram correlates of open field behavior in the rat: support for a sensorimotor function of hippocampal rhythmical synchronous activity. | Q48354400 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurogenesis | Q1456827 |
cell death | Q2383867 | ||
P304 | page(s) | 2083-2098 | |
P577 | publication date | 2005-07-07 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis | |
P478 | volume | 115 |
Q58547418 | A New Approach to Cerebral Palsy Treatment: Discussion of the Effective Components of Umbilical Cord Blood and its Mechanisms of Action |
Q48189448 | A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). |
Q36971669 | A novel combinatorial therapy with pulp stem cells and granulocyte colony-stimulating factor for total pulp regeneration |
Q48818770 | A novel flow cytometry-based technique to measure adult neurogenesis in the brain |
Q45947469 | A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. |
Q35887444 | A possible role for the immune system in adult neurogenesis: new insights from an invertebrate model |
Q33933699 | A screen for peptide agonists of the G-CSF receptor |
Q36655337 | Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease |
Q38779620 | Activation of bone marrow-derived microglia promotes photoreceptor survival in inherited retinal degeneration |
Q38302511 | Adjuvant granulocyte colony-stimulating factor therapy results in improved spatial learning and stimulates hippocampal neurogenesis in a mouse model of pneumococcal meningitis. |
Q43466093 | Aging aggravates ischemic stroke-induced brain damage in mice with chronic peripheral infection. |
Q36903124 | An early granulocyte colony-stimulating factor treatment attenuates neuropathic pain through activation of mu opioid receptors on the injured nerve |
Q33260756 | An extended window of opportunity for G-CSF treatment in cerebral ischemia |
Q42046756 | Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. |
Q39056339 | Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases |
Q33943588 | Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model |
Q93075906 | Antiapoptotic Effect of Granulocyte-Colony Stimulating Factor After Peripheral Nerve Trauma |
Q36297305 | Apoptosis-inducing factor downregulation increased neuronal progenitor, but not stem cell, survival in the neonatal hippocampus after cerebral hypoxia-ischemia |
Q44788657 | Assessing olfactory functions in patients with Barth syndrome |
Q34036456 | Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells |
Q92119058 | Autologous cord blood in children with cerebral palsy: a review |
Q27026889 | Autonomic nervous system and immune system interactions |
Q59808726 | Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients |
Q47935377 | Bone marrow drives central nervous system regeneration after radiation injury. |
Q37447090 | Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats |
Q36804531 | Bone marrow-derived stem cells in neurological diseases: stones or masons? |
Q37214453 | Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy. |
Q38900723 | CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family |
Q36023980 | CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. |
Q34556952 | CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit |
Q91707651 | Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options |
Q92193226 | Cancer stem cells in neuroblastoma therapy resistance |
Q35459801 | Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection |
Q83825682 | Cell therapy for ischaemic stroke |
Q48403988 | Cell type specific signalling by hematopoietic growth factors in neural cells |
Q34547149 | Cellular players of hematopoietic stem cell mobilization in the bone marrow niche. |
Q49700133 | Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming. |
Q97543439 | Characterization of G-CSF receptor expression in medulloblastoma |
Q27305612 | Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse |
Q48371870 | Cognitive impairment in heart failure: A protective role for angiotensin-(1-7). |
Q24201855 | Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke |
Q24245166 | Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke |
Q24245243 | Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke |
Q52588556 | Combination of G-CSF administration and human amniotic fluid mesenchymal stem cell transplantation promotes peripheral nerve regeneration. |
Q34409696 | Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury |
Q39747076 | Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer's disease mouse model |
Q38618826 | Control of Cell Survival in Adult Mammalian Neurogenesis |
Q37663926 | Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model |
Q31143549 | Development of new stroke therapies: outlook for neuroprotective drugs |
Q47386342 | Differential regulation of NSC phenotype and genotype by chronically activated microglia within cocultures |
Q27319805 | Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip |
Q44888340 | Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease |
Q35780806 | Duchenne muscular dystrophy: current cell therapies |
Q34726647 | Dynamic and extensive metabolic state-dependent regulation of cytokine expression and circulating levels |
Q35973656 | Effect of granulocyte-colony stimulating factor on expression of selected proteins involved in regulation of apoptosis in the brain of newborn piglets after cardiopulmonary bypass and deep hypothermic circulatory arrest |
Q55033159 | Effect of human recombinant granulocyte colony-stimulating factor on rat busulfan-induced testis injury. |
Q91607175 | Effect of the HDAC Inhibitor, Sodium Butyrate, on Neurogenesis in a Rat Model of Neonatal Hypoxia-Ischemia: Potential Mechanism of Action |
Q41181881 | Effects of an Inhibitor of Monocyte Recruitment on Recovery from Traumatic Brain Injury in Mice Treated with Granulocyte Colony-Stimulating Factor. |
Q34319576 | Efficacy of granulocyte-colony stimulating factor treatment in a rat model of anterior ischemic optic neuropathy |
Q110597015 | Elevated granulocyte-colony stimulating factor and hematopoietic stem cell mobilization in Niemann-Pick Type C1 disease |
Q98473609 | Emerging Therapeutic Strategies for Traumatic Spinal Cord Injury |
Q38100263 | Emerging neuroprotective drugs for the treatment of acute ischaemic stroke |
Q48602534 | Endogenous granulocyte colony-stimulating factor: a biomarker in acute ischemic stroke |
Q36872684 | Endotoxemia-induced cytokine-mediated responses of hippocampal astrocytes transmitted by cells of the brain-immune interface |
Q41907097 | Enhanced and Secretory Expression of Human Granulocyte Colony Stimulating Factor by Bacillus subtilis SCK6. |
Q51767535 | Enhancing endogenous capacity to repair a stroke-damaged brain: An evolving field for stroke research. |
Q35620417 | Expression of brain derived-neurotrophic factor and granulocyte-colony stimulating factor in the urothelium: relation with voiding function. |
Q39570530 | Expression of granulocyte colony stimulating factor and its receptor by retinal pigment epithelial cells: a role in maintaining differentiation-competent state. |
Q42835958 | Expression of granulocyte colony-stimulating factor 3 receptor in the spinal dorsal horn following spinal nerve ligation-induced neuropathic pain. |
Q39003470 | Extracellular molecules in hematopoietic stem cell mobilisation |
Q38977037 | Fractone-heparan sulphates mediate FGF-2 stimulation of cell proliferation in the adult subventricular zone |
Q35890570 | Functional Improvement after Photothrombotic Stroke in Rats Is Associated with Different Patterns of Dendritic Plasticity after G-CSF Treatment and G-CSF Treatment Combined with Concomitant or Sequential Constraint-Induced Movement Therapy |
Q90629399 | G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) |
Q35752008 | G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation. |
Q38892537 | G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease. |
Q61081210 | G-CSF Receptor Structure, Function, and Intracellular Signal Transduction |
Q41185045 | G-CSF administration attenuates brain injury in rats following carbon monoxide poisoning via different mechanisms |
Q34170943 | G-CSF administration is neuroprotective following transient cerebral ischemia even in the absence of a functional NOS-2 gene |
Q38342285 | G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury |
Q37570899 | G-CSF for mobilizing transplanted bone marrow stem cells in rat model of Parkinson's disease. |
Q28477416 | G-CSF prevents the progression of structural disintegration of white matter tracts in amyotrophic lateral sclerosis: a pilot trial |
Q35596594 | G-CSF protects human brain vascular endothelial cells injury induced by high glucose, free fatty acids and hypoxia through MAPK and Akt signaling |
Q30493856 | G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice |
Q34981973 | G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic |
Q36229391 | G-CSF rescues the memory impairment of animal models of Alzheimer's disease |
Q40516010 | G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke |
Q39317670 | G-CSF-mobilized Bone Marrow Mesenchymal Stem Cells Replenish Neural Lineages in Alzheimer's Disease Mice via CXCR4/SDF-1 Chemotaxis |
Q36227832 | G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis |
Q43599090 | GM-CSF protects rat photoreceptors from death by activating the SRC-dependent signalling and elevating anti-apoptotic factors and neurotrophins |
Q41561595 | GRP75 Involves in Retinal Ganglion Cell Apoptosis After Rat Optic Nerve Crush |
Q35613992 | Gender-Specific Mechanism of Synaptic Impairment and Its Prevention by GCSF in a Mouse Model of ALS. |
Q90700313 | Genotypic and phenotypic characterization of West Nile virus NS5 methyltransferase mutants |
Q24615554 | Ginsenoside rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic window |
Q57284893 | Granulocyte Colony Stimulating Factor Enhances Reward Learning through Potentiation of Mesolimbic Dopamine System Function |
Q47566621 | Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury |
Q55209440 | Granulocyte Colony-Stimulating Factor Alleviates Bacterial-Induced Neuronal Apoptotic Damage in the Neonatal Rat Brain through Epigenetic Histone Modification. |
Q48180769 | Granulocyte Colony-Stimulating Factor and Its Potential Application for Skeletal Muscle Repair and Regeneration. |
Q39981228 | Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients |
Q35137333 | Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis. |
Q34985230 | Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice |
Q53216544 | Granulocyte colony stimulating factor neuroprotective effects on spinal motoneurons after ventral root avulsion. |
Q34694819 | Granulocyte colony stimulating factor reduces brain injury in a cardiopulmonary bypass-circulatory arrest model of ischemia in a newborn piglet |
Q33563023 | Granulocyte colony stimulating factor therapy for stroke: A pairwise meta-analysis of randomized controlled trial |
Q34300608 | Granulocyte colony-stimulating factor (G-CSF) positive effects on muscle fiber degeneration and gait recovery after nerve lesion in MDX mice. |
Q34500255 | Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats |
Q34630942 | Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats |
Q36740527 | Granulocyte colony-stimulating factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans |
Q21136403 | Granulocyte colony-stimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticity |
Q35591273 | Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis |
Q44359967 | Granulocyte colony-stimulating factor does not promote neurogenesis after experimental intracerebral haemorrhage. |
Q42920403 | Granulocyte colony-stimulating factor enhances cellular proliferation and motor function recovery on rats subjected to traumatic brain injury |
Q45979710 | Granulocyte colony-stimulating factor increases sympathetic reinnervation and the arrhythmogenic response to programmed electrical stimulation after myocardial infarction in rats. |
Q48687818 | Granulocyte colony-stimulating factor off-target effect on nerve outgrowth promotes prostate cancer development. |
Q36723127 | Granulocyte colony-stimulating factor promotes behavioral recovery in a mouse model of traumatic brain injury. |
Q48697355 | Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation |
Q47724526 | Granulocyte colony-stimulating factor significantly decreases density of hippocampal caspase 3-positive nuclei, thus ameliorating apoptosis-mediated damage, in a model of ischaemic neonatal brain injury |
Q33780538 | Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. |
Q53452061 | Granulocyte macrophage-colony stimulating factor shows anti-apoptotic activity in neural progenitor cells via JAK/STAT5-Bcl-2 pathway |
Q37041123 | Granulocyte stimulating factor attenuates hypoxic-ischemic brain injury by inhibiting apoptosis in neonatal rats. |
Q33772176 | Granulocyte-Colony Stimulating Factor (G-CSF) Accelerates Wound Healing in Hemorrhagic Shock Rats by Enhancing Angiogenesis and Attenuating Apoptosis. |
Q36192434 | Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis |
Q53439244 | Granulocyte-Colony Stimulating Factor Increases Cerebral Blood Flow via a NO Surge Mediated by Akt/eNOS Pathway to Reduce Ischemic Injury. |
Q28732850 | Granulocyte-colony stimulating factor (G-CSF) improves motor recovery in the rat impactor model for spinal cord injury |
Q28744358 | Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease--a randomized controlled trial |
Q36093819 | Granulocyte-colony stimulating factor activates JAK2/PI3K/PDE3B pathway to inhibit corticosterone synthesis in a neonatal hypoxic-ischemic brain injury rat model. |
Q48940108 | Granulocyte-colony stimulating factor alleviates perinatal hypoxia-induced decreases in hippocampal synaptic efficacy and neurogenesis in the neonatal rat brain |
Q38481539 | Granulocyte-colony stimulating factor ameliorates irradiation-induced suppression of hippocampal neurogenesis in adult mice |
Q57153034 | Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury |
Q35213148 | Granulocyte-colony stimulating factor attenuates oligomeric amyloid β neurotoxicity by activation of neprilysin |
Q47861165 | Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine |
Q34330344 | Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model |
Q37689522 | Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies |
Q42854392 | Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: an experimental exploratory study |
Q24655277 | Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis |
Q39562503 | Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment. |
Q35836825 | Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats |
Q48873132 | Granulocyte-colony stimulating factor promotes brain repair following traumatic brain injury by recruitment of microglia and increasing neurotrophic factor expression |
Q35088982 | Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats |
Q51010634 | Granulocyte-colony stimulating factor protects memory impairment in the senescence-accelerated mouse (SAM)-P10. |
Q46878329 | Granulocyte-colony stimulating factor: a new player for the enteric nervous system |
Q49646739 | Granulocyte-colony-stimulating factor (G-CSF) signaling in spinal microglia drives visceral sensitization following colitis |
Q94400913 | Granulocyte‐colony stimulating factor administration for subfertile women undergoing assisted reproduction |
Q36608807 | Growth factors and stroke |
Q54189658 | Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis. |
Q35216143 | Growth factors in ischemic stroke. |
Q60678255 | Hematopoietic colony–stimulating factors mediate tumor-nerve interactions and bone cancer pain |
Q42024722 | Hematopoietic growth factors pass through the blood-brain barrier in intact rats |
Q38816820 | Hematopoietic stem and progenitor cells as novel prognostic biomarkers of longevity in a murine model for amyotrophic lateral sclerosis |
Q36824005 | Hematopoietic stem cells are pluripotent and not just "hematopoietic". |
Q38190431 | Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets |
Q39306350 | Hippocampal neurogenesis and the brain repair response to brief stereotaxic insertion of a microneedle. |
Q37592633 | Histological Architecture Underlying Brain-Immune Cell-Cell Interactions and the Cerebral Response to Systemic Inflammation |
Q43216252 | Hypothalamic proline rich polypeptide regulates hematopoiesis |
Q45874222 | Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury |
Q40804722 | IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus |
Q34244910 | Immune system modulates the function of adult neural stem cells. |
Q34158254 | Immunological control of adult neural stem cells |
Q34451574 | Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. |
Q40754685 | Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke |
Q37572370 | Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. |
Q37091669 | Improving outcome after stroke: overcoming the translational roadblock |
Q47704356 | In Vitro Microfluidic Models for Neurodegenerative Disorders. |
Q48327541 | In vivo administration of granulocyte colony-stimulating factor restores long-term depression in hippocampal slices prepared from transgenic APP/PS1 mice |
Q45938256 | Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease. |
Q48380634 | Increased recruitment of bone marrow-derived cells into the brain associated with altered brain cytokine profile in senescence-accelerated mice |
Q38703435 | Induction of Neurorestoration From Endogenous Stem Cells |
Q37474699 | Inflammatory Disequilibrium in Stroke |
Q37997911 | Inflammatory regulators of redirected neural migration in the injured brain |
Q33568772 | Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro |
Q35459565 | Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats |
Q40245798 | Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis |
Q35648103 | Investigational therapies for ischemic stroke: neuroprotection and neurorecovery |
Q48600819 | Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. |
Q37686762 | Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury |
Q42053383 | LIM domain only 4 protein promotes granulocyte colony-stimulating factor-induced signaling in neurons |
Q35098308 | Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats |
Q34011525 | Maintenance of the enteric stem cell niche by bacterial lipopolysaccharides? Evidence and perspectives |
Q37421064 | Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis |
Q41827325 | Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model |
Q28082627 | Microglia are crucial regulators of neuro-immunity during central nervous system tuberculosis |
Q26773064 | Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice |
Q34009248 | Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trial |
Q37027281 | Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities |
Q34059585 | Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice |
Q47303075 | Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up. |
Q40350912 | Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke. |
Q42697596 | Mononuclear cells from the cord blood and granulocytecolony stimulating factor-mobilized peripheral blood: is there a potential for treatment of cerebral palsy? |
Q36437332 | Motor neuron-immune interactions: the vicious circle of ALS. |
Q37358654 | Multifunctional actions of approved and candidate stroke drugs |
Q33789162 | Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone. |
Q34473745 | Multimodality monitoring, inflammation, and neuroregeneration in subarachnoid hemorrhage |
Q37233361 | Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue |
Q53059092 | Nephro-protective effect of granulocyte colony-stimulating factor in streptozotocin induced diabetic rats. |
Q36275171 | Neural precursor cells are protected from apoptosis induced by trophic factor withdrawal or genotoxic stress by inhibitors of glycogen synthase kinase 3. |
Q27001127 | Neural precursor cells in the ischemic brain - integration, cellular crosstalk, and consequences for stroke recovery |
Q37085039 | Neural stem cells in the mammalian brain |
Q38622588 | Neurogenesis following Stroke Affecting the Adult Brain |
Q33370650 | Neuronal hypoxia in vitro: investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells |
Q36829280 | Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin. |
Q37991061 | Neuroprotection for ischaemic stroke: translation from the bench to the bedside |
Q26853031 | Neuroprotection for stroke: current status and future perspectives |
Q48077973 | Neuroprotective Effects of Direct Intrathecal Administration of Granulocyte Colony-Stimulating Factor in Rats with Spinal Cord Injury |
Q47868304 | Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects |
Q36680605 | Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis |
Q45719870 | Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17. |
Q37028288 | Neurorestoration after stroke. |
Q33985590 | Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? |
Q34240286 | Neutrophil contribution to spinal cord injury and repair |
Q55191874 | Neutrophils in traumatic brain injury (TBI): friend or foe? |
Q34461560 | New hope for stroke patients: mobilization of endogenous stem cells |
Q36445653 | Noninvasive tracking of gene transcript and neuroprotection after gene therapy |
Q35953384 | Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields |
Q54962608 | Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS). |
Q39639495 | Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease. |
Q28486022 | Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria |
Q43092577 | Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease |
Q36883767 | Potential roles of bone marrow stem cells in stroke therapy |
Q36151822 | Preliminary study on electrophysiological changes after cellular autograft in age-related macular degeneration |
Q50979109 | Prevention of an increase in cortical ligand binding to AMPA receptors may represent a novel mechanism of endogenous brain protection by G-CSF after ischemic stroke. |
Q39191007 | Production of IL-8, IL-17, IFN-gamma and IP-10 in human astrocytes correlates with alphavirus attenuation |
Q36216243 | Profiling and Identification of Novel Immunogenic Proteins of Staphylococcus hyicus ZC-4 by Immunoproteomic Assay |
Q38107439 | Progress in stem cell therapy for major human neurological disorders. |
Q47106198 | Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury |
Q38675024 | Promoting recovery from ischemic stroke |
Q38476445 | Protection of spermatogenesis against gamma ray-induced damage by granulocyte colony-stimulating factor in mice |
Q48787833 | Protective effect of granulocyte colony-stimulating factor on intracerebral hemorrhage in rat. |
Q52603658 | Recent Advances: Decoding Alzheimer's Disease With Stem Cells. |
Q48382225 | Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/Bax expression levels |
Q51697440 | Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis. |
Q47779952 | Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: A pilot study |
Q56927463 | Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report |
Q40355155 | Regulatory issues in aging pharmacology |
Q42970221 | Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor func |
Q33862328 | Role of neural precursor cells in promoting repair following stroke |
Q36830938 | Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches |
Q37190629 | Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration |
Q36709806 | Role of the pituitary–adrenal axis in granulocyte-colony stimulating factor-induced neuroprotection against hypoxia–ischemia in neonatal rats |
Q38446890 | Safety and efficacy of G-CSF mobilization and collection of autologous peripheral blood stem cells in children with cerebral palsy |
Q38757929 | Secretome Cues Modulate the Neurogenic Potential of Bone Marrow and Dental Stem Cells |
Q37817069 | Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brain |
Q55228910 | Serial Changes of Cytokines in Children with Cerebral Palsy Who Received Intravenous Granulocyte-colony Stimulating Factor Followed by Autologous Mobilized Peripheral Blood Mononuclear Cells. |
Q41903809 | Serum granulocyte colony-stimulating factor and Alzheimer's disease |
Q51832847 | Sesamol ameliorates radiation induced DNA damage in hematopoietic system of whole body γ-irradiated mice. |
Q31152401 | Soluble prokaryotic overexpression and purification of bioactive human granulocyte colony-stimulating factor by maltose binding protein and protein disulfide isomerase |
Q88998644 | Stem Cell Factor in Combination with Granulocyte Colony-Stimulating Factor reduces Cerebral Capillary Thrombosis in a Mouse Model of CADASIL |
Q38903653 | Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration |
Q34129832 | Stem cell therapy for cerebral ischemia: from basic science to clinical applications |
Q33981407 | Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor |
Q37053159 | Stem cells and neurological diseases. |
Q37453637 | Stem cells for enhancing recovery after stroke: a review. |
Q33957236 | Stem cells for ischemic brain injury: a critical review |
Q53825391 | Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury. |
Q28475375 | Synergetic effects of granulocyte-colony stimulating factor and cognitive training on spatial learning and survival of newborn hippocampal neurons |
Q40961556 | System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice |
Q93090713 | Systemic Factors Trigger Vasculature Cells to Drive Notch Signaling and Neurogenesis in Neural Stem Cells in the Adult Brain |
Q41229573 | Targeting Adult Neurogenesis for Poststroke Therapy |
Q26798071 | The Granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity |
Q54748291 | The arrythmogenic potential of post-myocardial infarction cytokine treatment. |
Q36713511 | The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia |
Q46441301 | The effect of granulocyte colony-stimulating factor administration on carbon monoxide neurotoxicity in rats. |
Q41959494 | The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats |
Q27305224 | The effects of hematopoietic growth factors on neurite outgrowth |
Q30463376 | The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions |
Q33303476 | The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro |
Q30460097 | The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors |
Q38275171 | The ongoing pursuit of neuroprotective therapies in Parkinson disease |
Q30855096 | The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review |
Q21284135 | The receptor for granulocyte-colony stimulating factor (G-CSF) is expressed in radial glia during development of the nervous system |
Q36055381 | The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome |
Q43275672 | The role of granulocyte-colony stimulating factor (G-CSF) in the healthy brain: a characterization of G-CSF-deficient mice |
Q37087845 | The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke |
Q55100841 | Toll-like receptor 2 promotes neurogenesis from the dentate gyrus after photothrombotic cerebral ischemia in mice. |
Q36789097 | Transcriptional regulation of neurogenesis: potential mechanisms in cerebral ischemia |
Q36522091 | Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke |
Q36523745 | Transplantation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Restores the Neurobehavioral Disorders of Rats With Neonatal Hypoxic-Ischemic Encephalopathy |
Q36274847 | Transplantation of adult neural progenitor cells transfected with vascular endothelial growth factor rescues grafted cells in the rat brain |
Q47286190 | Turning Death to Growth: Hematopoietic Growth Factors Promote Neurite Outgrowth through MEK/ERK/p53 Pathway. |
Q48583625 | Umbilical cord blood cell and granulocyte-colony stimulating factor: combination therapy for traumatic brain injury |
Q37762259 | Use of growth factors for the treatment of Parkinson's disease |
Q48293605 | Voluntary exercise enhances survival and migration of neural progenitor cells after intracerebral haemorrhage in mice |
Q61803794 | Zinc Improves Functional Recovery by Regulating the Secretion of Granulocyte Colony Stimulating Factor From Microglia/Macrophages After Spinal Cord Injury |
Q35602819 | pH responsive granulocyte colony-stimulating factor variants with implications for treating Alzheimer's disease and other central nervous system disorders |
Search more.